Manning & Napier Group's BIIB Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 26 shares of Biogen Inc. (BIIB) worth $6,558, representing 0.00% of the portfolio. First purchased in 2017-Q1, this long-term strategic position has been held for 39 quarters.
Based on 13F filings, Manning & Napier Group has maintained a strategic position in BIIB, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2017, adding 691,694 shares. Largest reduction occurred in Q4 2017, reducing 331,082 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Biogen (BIIB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Biogen (BIIB) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +26 | New Buy | 26 | $252.23 |
| Q4 2018 | -178,560 | Sold Out | 178,560 | $353.30 |
| Q3 2018 | -38,930 | Reduce 17.90% | 178,560 | $353.30 |
| Q2 2018 | -172,760 | Reduce 44.27% | 217,490 | $290.23 |
| Q1 2018 | -16,403 | Reduce 4.03% | 390,250 | $273.81 |
| Q4 2017 | +406,654 | Add 0.00% | 406,653 | $318.57 |
| Q3 2017 | -76,634 | Reduce 9.41% | 737,735 | $313.12 |
| Q2 2017 | +691,694 | Add 563.84% | 814,369 | $271.36 |
| Q1 2017 | +122,675 | New Buy | 122,675 | $273.41 |
Manning & Napier Group's Biogen Investment FAQs
Manning & Napier Group first purchased Biogen Inc. (BIIB) in Q1 2017, acquiring 122,675 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Biogen Inc. (BIIB) for 39 quarters since Q1 2017.
Manning & Napier Group's largest addition to Biogen Inc. (BIIB) was in Q2 2017, adding 814,369 shares worth $220.99 M.
According to the latest 13F filing for Q3 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 26 shares of Biogen Inc. (BIIB), valued at approximately $6,558.
As of the Q3 2026 filing, Biogen Inc. (BIIB) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Biogen Inc. (BIIB) was 814,369 shares, as reported at the end of Q2 2017.